The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event

Cannabidiol as a Treatment for Mental Health Outcomes Among Health Care Workers During the Coronavirus Disease Pandemic

(2021) Júlia Cozar Pacheco et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic

(2021) José Alexandre S. Crippa et al.   JAMA Network Open

Clinical validity and intrarater and test‐retest reliability of the Structured Clinical Interview for DSM‐5 Disorders‐Clinician Version (SCID‐5‐CV)

(2019) Flávia Lima Osório et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

The Influence of Trauma Type and Timing on PTSD Symptoms

(2018) Jeffrey Guina et al.   JOURNAL OF NERVOUS AND MENTAL DISEASE

Neurocognitive and Information Processing Biases in Posttraumatic Stress Disorder

(2018) Jennifer J. Vasterling et al.   Current Psychiatry Reports

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life

(2017) Antonio W. Zuardi et al.   Frontiers in Pharmacology

Cannabidiol presents an inverted U-shaped dose-response curve in the simulated public speaking test

(2016) I. Linares et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational Investigation

(2012) Antonio Waldo Zuardi et al.   CURRENT PHARMACEUTICAL DESIGN

On Disruption of Fear Memory by Reconsolidation Blockade: Evidence from Cannabidiol Treatment

(2012) Cristina A J Stern et al.   NEUROPSYCHOPHARMACOLOGY

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

(2011) Mateus M Bergamaschi et al.   NEUROPSYCHOPHARMACOLOGY